About: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 August 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) article scientifique publié en 2006 (fr) наукова стаття, опублікована в серпні 2006 (uk) im August 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 28 August 2006 (en) artículu científicu espublizáu n'agostu de 2006 (ast)
publication date	wds:Q80184823-3E7009C7-9A98-4787-B7BB-B7B7092C9D08
publication date	2006-08-28 00:00:00Z (xsd:dateTime)
author name string	wds:Q80184823-0E3CEF7D-65F0-4FA2-B6FA-47EC0BDB0918 wds:Q80184823-266D11AF-2017-4D66-94A9-1B52967C3C10 wds:Q80184823-2E5AAC2B-AA63-4080-B377-E2B0E47E3F06 wds:Q80184823-3E0739B1-1C20-4D23-A58D-BE36CCD68D0F wds:Q80184823-40D1FBC0-DDB4-4BA1-8E41-91049BB909FE wds:Q80184823-6410A43F-7858-44C7-9033-71E80A914DD8 wds:Q80184823-6C627BD5-7DB9-4453-823C-105861C15BED wds:Q80184823-705A163F-9036-4133-BEF9-F8C9F4E2477C wds:Q80184823-C9D55C59-6E85-49AD-A337-960CD089E111 wds:Q80184823-D743556A-4028-41B3-9F36-ADB00B61C84A wds:Q80184823-E1C29D68-9914-4B7D-80C1-EB1E2438CEC0 wds:Q80184823-E46EA6D6-666A-4D4D-BC17-BE6E60A71DE6
author name string	H McDonald S Oliver R Chalmers K Chakravarty T Kennedy M Somerville T Pullar J Mooney A Bosworth A Taggart British Association of Dermatologists (BAD) British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group
rdfs:label	BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (en) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (nl)
skos:prefLabel	BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (en) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (nl)
name	BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (en) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (nl)
title	wds:Q80184823-3B65C314-353B-4914-9339-B87EE8575173
title	BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists (en)
page(s)	wds:Q80184823-1948AA54-2123-40C3-8A0C-FF1E04654391
page(s)	924-925
instance of	wds:Q80184823-2338CD0D-9176-4024-9282-02766F35CE7D
instance of	scholarly article
PubMed ID	wds:Q80184823-A8A11321-976D-4CA1-BC7B-A0DC1276A29C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16940305
PubMed ID	16940305
published in	wds:Q80184823-6E9875E4-2F5F-446F-B9F6-4344A4A58AD0
published in	Rheumatology
issue	wds:Q80184823-D7792F2A-CD3B-4880-A620-F745D90F8C2A
volume	wds:Q80184823-CF0EC5D4-0C24-4413-8F8D-297F8DB29DA7
issue	6
volume	47
DOI	wds:Q80184823-931CFE45-225F-4F50-9A5D-057F498E8504
DOI	http://dx.doi.org/10.1093/RHEUMATOLOGY/KEL216A
DOI	10.1093/RHEUMATOLOGY/KEL216A
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80184823
is cites work of	Rheumatoid arthritis Pharmacotherapy for uveitis: current management and emerging therapy Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis Implementation of TPMT testing Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases Diagnosis and treatment of urticaria and angioedema: a worldwide perspective Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study). Complications of long-term therapy for ANCA-associated systemic vasculitis. Peculiar Presentation of Ulcerative Colitis Good practice in shared care for inflammatory arthritis Risk of liver disease in methotrexate treated patients Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe Bioadhesive Surfactant Systems for Methotrexate Skin Delivery. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy. Wound healing with medications for rheumatoid arthritis in hand surgery Methotrexate: an effective monotherapy for refractory generalized morphea Neutropenia in the Elderly: A Rheumatology Perspective Systemic therapy for vulval Erosive Lichen Planus (the 'hELP' trial): study protocol for a randomised controlled trial Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Management Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients Checklists for safe prescribing in oral medicine clinics. Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. "Living a normal life": a qualitative study of patients' views of medication withdrawal in rheumatoid arthritis Lessons From LEADER - All-round Leadership LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy Rheumatoid polyarthritis suspected in an HIV patient with scleritis, peripheral ulcerative keratitis, and anterior uveitis The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis. Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis. A Case of Concomitant Pemphigus Foliaceus and Oral Pemphigus Vulgaris.
is cites work of	wds:Q34642567-7EEC1585-96B2-4181-951A-B59086074BD7 wds:Q35789299-FD501C22-30F8-4B3C-A535-FD3312EC5075 wds:Q37678056-5B4AF0BA-A2B2-42B6-9E58-B00B6B19EE91 wds:Q39216560-1FC8DF2C-FA95-43DE-B667-48519A3DE7F3 wds:Q52640450-FE383D3A-3A70-4CBC-A2BA-4139B280D9F6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software